Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

Scinai Immunotherapeutics Ltd. (SCNI) Institutional Ownership & Insider Trading

11 institutions reported holding Scinai Immunotherapeutics Ltd. shares in 13F filings for the quarter ended 2026-06-30, according to EquiReason's reading of their SEC filings.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

SCNIScinai Immunotherapeutics Ltd.Follow SCNI — free
Biotechnology · Healthcare
—
Price chart with a free account
Market cap
3.2M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
—

Institutions · all 13F filers

quarter to 30 Jun 2026 · filers in both quarters

11 institutions held 0.0% of the shares. Across filers that reported both quarters, shares held changed —.

Increased+2New+7Decreased-1Closed+0

Largest moves, shares (millions)

Citadel Advisors+0.1MArmistice Capital+0.0MVirtu Financial+0.0MXTX Topco-0.0M

Institutional flow by quarter

net shares added or trimmed, millions · filers in both quarters
-0.0Sep 24+0.0Dec 24-0.0Mar 25+0.0Jun 25-0.0Sep 25+0.0Dec 25-0.1Mar 26+0.2Jun 26
QuarterHoldersShares held, MChangeIncreasedNewDecreasedClosed
Jun 26110—2710
Mar 2640—0023
Dec 2570—2221
Sep 2560—2222
Jun 2550—1210
Mar 2540—0020
Dec 2440—1000
Sep 2450—1024

Scinai Immunotherapeutics Ltd. — questions

Who owns Scinai Immunotherapeutics Ltd. stock?
11 institutions reported Scinai Immunotherapeutics Ltd. shares in 13F filings for the quarter ended 2026-06-30. The largest: CITADEL ADVISORS LLC (0.0%), ARMISTICE CAPITAL, LLC (0.0%), Virtu Financial LLC (0.0%).

Every figure on this page comes from Scinai Immunotherapeutics Ltd.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.